3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
5
Thoracic
1
Gynecologic
1
Breast
1
Conditions
Ovarian Neoplasms
11
Carcinoma, Ovarian Epithelial
11
Uterine Cervical Neoplasms
6
Fallopian Tube Neoplasms
6
Breast Neoplasms
5
Endometrial Neoplasms
3
Uterine Cervical Dysplasia
2
Testicular Neoplasms
2
Sarcoma
2
Salivary Gland Neoplasms
2
Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Liver Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Burkitt Lymphoma
2
Wilms Tumor
1
Vulvar Neoplasms
1
Urinary Bladder Neoplasms
1
Testicular Germ Cell Tumor
1
Teratoma
1
Squamous Intraepithelial Lesions
1
Squamous Cell Carcinoma of Head and Neck
1
Spinal Cord Neoplasms
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Rhabdoid Tumor
1
Recurrence
1
Prostatic Neoplasms
1
Interventions
pembrolizumab
2
Nivolumab
2
Carboplatin
2
tislelizumab
1
spartalizumab
1
ribociclib
1
obinutuzumab
1
naptumomab estafenatox
1
durvalumab
1
abemaciclib
1
Polymerase Chain Reaction
1
Mass Spectrometry
1
In Situ Hybridization, Fluorescence
1
Immunohistochemistry
1
Fulvestrant
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adenocarcinoma Of Esophagus
×
Immunohistochemistry
×
Gynecologic
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled